Format

Send to

Choose Destination
See comment in PubMed Commons below
Br J Clin Pharmacol. 2013 Jul;76(1):21-9. doi: 10.1111/bcp.12113.

Randomized controlled trials of antibiotics for neonatal infections: a systematic review.

Author information

1
Department of Paediatric Pharmacology and Pharmacogenetics, INSERM CIC9202, Hopital Robert Debré, 48 boulevard Serurier, Paris, France. florentia.kaguelidou@rdb.aphp.fr

Erratum in

  • Br J Clin Pharmacol. 2013 Nov;76(5):840. van Anker, John [corrected to van den Anker, John].

Abstract

AIMS:

Antibiotics are a key resource for the management of infectious diseases in neonatology and their evaluation is particularly challenging. We reviewed medical literature to assess the characteristics and quality of randomized controlled trials on antibiotics in neonatal infections.

METHODS:

We performed a systematic search of PubMed, Embase and the Cochrane Library from January 1995 to March 2010. Bibliographies of relevant articles were also hand-searched. We included all randomized controlled trials that involved neonates and evaluated the use of an antibiotic agent in the context of a neonatal infectious disease. Methodological quality was evaluated using the Jadad scale and the Cochrane Risk of Bias Tool. Two reviewers independently assessed studies for inclusion and evaluated methodological quality.

RESULTS:

A total of 35 randomized controlled trials were evaluated. The majority were conducted in a single hospital institution, without funding. Median sample size was 63 (34-103) participants. The most frequently evaluated antibiotic was gentamicin. Respectively, 18 (51%) and 17 (49%) trials evaluated the therapeutic or prophylactic use of antibiotics in various neonatal infections. Overall, the methodological quality was poor and did not improve over the years. Risk of bias was high in 66% of the trials.

CONCLUSIONS:

Design and reporting of randomized controlled trials of antibacterial agents in neonates should be improved. Nevertheless, the necessity of implementing such trials when antibacterial efficacy has already been established in other age groups may be questioned and different methods of evaluation should be further developed.

PMID:
23488627
PMCID:
PMC3703225
DOI:
10.1111/bcp.12113
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley Icon for PubMed Central
    Loading ...
    Support Center